Celgene Corporation’s $5 Billion Bridge Commitment and $1 Billion Revolving Credit Facility
July 29, 2015
Cravath represented JPMorgan Chase Bank, N.A. as arranger of a $5 billion bridge commitment and a $1 billion revolving credit facility to support Celgene Corporation’s acquisition of Receptos, Inc. Celgene Corporation is a global biopharmaceutical company with a primary focus in developing therapies to treat cancer and inflammatory diseases. The transaction closed on July 29, 2015.
The Cravath team included partners James D. Cooper and Stephen L. Burns, senior attorney Patrick J. Moriarty and associates Jacob B. Ornstein and Saarah Woodby on banking and securities matters; and partner David J. Kappos and senior attorney Anthony N. Magistrale on intellectual property matters. Summer associate Stephanie M. Park also worked on banking matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 1990, University of California, Berkeley, School of Law
-
B.S., 1983, University of California, Davissumma cum laude
- New York
- California
- District of Columbia
Education
Admitted In
- Photo
-
-
J.D., 1979, Yale Law School
-
A.B., 1976, University of ChicagoPhi Beta Kappa, summa cum laude
Education
- Photo
-
-
J.D., 1990, The University of Texas School of Lawwith Honors
-
B.B.A., 1987, University of Oklahomawith Distinction
Education
Related News & Insights
Deals & Cases
July 13, 2026
Boluda Towage’s €2.45 Billion Term Loan and Revolving Credit Facilities
Cravath represented the agent, mandated lead arrangers and lenders in connection with Boluda Towage’s €2.15 billion (equivalent) term loan facility and €300 million multi‑currency revolving credit facility. The proceeds will be used towards refinancing certain existing credit facilities and for general corporate purposes. Boluda Towage is a leading maritime services operator. The transaction closed on June 30, 2026.
Deals & Cases
July 06, 2026
UVEX’s Upsize and Repricing of its Term Loan Facility
Cravath represented the agent, mandated lead arrangers, and lenders in connection with the repricing of UVEX GROUP GmbH’s €400 million term loan facility and €50 million term loan add-on. UVEX GROUP GmbH is a portfolio company of Warburg Pincus. The transaction closed on June 19, 2026.
Deals & Cases
April 06, 2026
Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
